{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T18:34:26Z","timestamp":1789929266892,"version":"4.0.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T00:00:00Z","timestamp":1481760000000},"content-version":"vor","delay-in-days":1689,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.vhri.2012.03.015","type":"journal-article","created":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T19:05:57Z","timestamp":1338577557000},"page":"59-65","source":"Crossref","is-referenced-by-count":8,"title":["Cost-Effectiveness of Sertindole among Atypical Antipsychotics in the Treatment of Schizophrenia in South Korea"],"prefix":"10.1016","volume":"1","author":[{"given":"Bo-Ra-Mi","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Hyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bong-Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vhri.2012.03.015_bib1","series-title":"The Epidemiological Survey of Psychiatric Illnesses in Korea 2006","author":"Cho","year":"2007"},{"key":"10.1016\/j.vhri.2012.03.015_bib2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1192\/bjp.150.3.285","article-title":"The burden of care: the impact of functional psychiatric illness on the patient's family","volume":"150","author":"Fadden","year":"1987","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.vhri.2012.03.015_bib4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF00788738","article-title":"Family burden in schizophrenia: implications for services","volume":"28","author":"Kuipers","year":"1993","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"10.1016\/j.vhri.2012.03.015_bib5","series-title":"Pharmacological Treatment of Schizophrenia","author":"Kim","year":"1998"},{"key":"10.1016\/j.vhri.2012.03.015_bib7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/pds.1594","article-title":"The Sertindole Cohort Prospective (SCoP) study: rationale, design and methodology","volume":"17","author":"Peuskens","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vhri.2012.03.015_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/13651500050518406","article-title":"Sertindole improves both the positive and negative symptoms of schizophrenia: results of a phase III trial","volume":"4","author":"Hale","year":"2000","journal-title":"Int J Psychiatry Clin Pract"},{"key":"10.1016\/j.vhri.2012.03.015_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.yic.0000177020.26311.a7","article-title":"A double-blind, controlled study of sertindole versus risperidone in the treatment of moderate-to-severe schizophrenia","volume":"21","author":"Azorin","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.vhri.2012.03.015_bib11","article-title":"Sertindole for schizophrenia","author":"Lewis","year":"2009","journal-title":"Systematic Reviews"},{"key":"10.1016\/j.vhri.2012.03.015_bib13","series-title":"Statistical Manual of Mental Disorders","author":"Frances","year":"2000"},{"key":"10.1016\/j.vhri.2012.03.015_bib14","series-title":"Guidance for Manufacturers and Sponsors: Technology Appraisals Process Series No. 5","year":"2001"},{"key":"10.1016\/j.vhri.2012.03.015_bib15","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vhri.2012.03.015_bib16","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/01.jcp.0000222513.63767.de","article-title":"A randomized, 1-year follow-up study of olanzapine and risperidone in the treatment of negative symptoms in outpatients with schizophrenia","volume":"26","author":"Alvarez","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.vhri.2012.03.015_bib17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.schres.2006.03.027","article-title":"A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization","volume":"85","author":"Potkin","year":"2006","journal-title":"Schizophr Res"},{"key":"10.1016\/j.vhri.2012.03.015_bib18","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.4088\/JCP.v67n0712","article-title":"Comparison of quetiapine and risperidone in the treatment of schizophrenia: a randomized, double-blind, flexible-dose, 8-week study","volume":"67","author":"Zhong","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.vhri.2012.03.015_bib19","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1176\/appi.ajp.158.5.765","article-title":"A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder","volume":"158","author":"Conley","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.vhri.2012.03.015_bib20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0920-9964(02)00226-8","article-title":"Olanzapine vs risperidone in the management of schizophrenia: a randomized double-blind trial in Australia and New Zealand","volume":"61","author":"Gureje","year":"2003","journal-title":"Schizophr Res"},{"key":"10.1016\/j.vhri.2012.03.015_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.eurpsy.2005.09.009","article-title":"Meta-analysis of drop-out rates in randomised clinical trials, comparing typical and atypical antipsychotics in the treatment of schizophrenia","volume":"21","author":"Martin","year":"2006","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.vhri.2012.03.015_bib22","doi-asserted-by":"crossref","unstructured":"Hansen K, Launois R, Sapin C. Pharmacoeconomic positioning of sertindole among atypical antipsychotics in the management of schizophrenia in Turkey. Presented in: iHEA 6th World Congress: Explorations in Health Economics. Copenhagen, Denmark, 2007.","DOI":"10.1016\/S1098-3015(10)63546-2"},{"key":"10.1016\/j.vhri.2012.03.015_bib23","first-page":"254","article-title":"Health-related quality of life using EQ-5D in Koreans","volume":"11","author":"Seong","year":"2004","journal-title":"J Korean Rheum Assoc"},{"key":"10.1016\/j.vhri.2012.03.015_bib25","series-title":"The Weighted Price of Drug by Component in the First Half Year of 2010","article-title":"Health Insurance Review and Assessment Service","year":"2011"},{"key":"10.1016\/j.vhri.2012.03.015_bib27","series-title":"Mental Illness Optimal Treatment Model for Each Type","author":"Na","year":"2001"},{"key":"10.1016\/j.vhri.2012.03.015_bib30","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00127-005-0955-5","article-title":"The European Schizophrenia Cohort (EuroSC): a naturalistic prognostic and economic study","volume":"40","author":"Bebbington","year":"2005","journal-title":"Soc Psychiatry Psychiatr Epidemiol"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109912000167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109912000167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T01:56:53Z","timestamp":1687485413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109912000167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S2212109912000167"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2012.03.015","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}